ID   DGLA_HUMAN              Reviewed;        1042 AA.
AC   Q9Y4D2; A7E233; Q6WQJ0;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 3.
DT   10-MAY-2017, entry version 127.
DE   RecName: Full=Sn1-specific diacylglycerol lipase alpha;
DE            Short=DGL-alpha;
DE            EC=3.1.1.-;
DE   AltName: Full=Neural stem cell-derived dendrite regulator;
GN   Name=DAGLA; Synonyms=C11orf11, KIAA0659, NSDDR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Horiguchi S., Tashiro K., Takahashi J., Hashimoto N., Nakano I.,
RA   Tsuchida Y., Hirai H., Honjo T.;
RT   "NSDDR a novel tetra-spanning transmembrane protein with a unique
RT   integration pattern to the plasma membrane regulates the extension of
RT   the dendritic trees of Purkinje cells.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=14610053; DOI=10.1083/jcb.200305129;
RA   Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G.,
RA   Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.-J.,
RA   Gangadharan U., Hobbs C., Di Marzo V., Doherty P.;
RT   "Cloning of the first sn1-DAG lipases points to the spatial and
RT   temporal regulation of endocannabinoid signaling in the brain.";
RL   J. Cell Biol. 163:463-468(2003).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=16051747; DOI=10.1124/mol.105.013961;
RA   Jung K.-M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M.,
RA   Mackie K., Piomelli D.;
RT   "Stimulation of endocannabinoid formation in brain slice cultures
RT   through activation of group I metabotropic glutamate receptors.";
RL   Mol. Pharmacol. 68:1196-1202(2005).
RN   [8]
RP   POSSIBLE INVOLVEMENT IN SCA20.
RX   PubMed=18801880; DOI=10.1093/hmg/ddn283;
RA   Knight M.A., Hernandez D., Diede S.J., Dauwerse H.G., Rafferty I.,
RA   van de Leemput J., Forrest S.M., Gardner R.J., Storey E.,
RA   van Ommen G.J., Tapscott S.J., Fischbeck K.H., Singleton A.B.;
RT   "A duplication at chromosome 11q12.2-11q12.3 is associated with
RT   spinocerebellar ataxia type 20.";
RL   Hum. Mol. Genet. 17:3847-3853(2008).
CC   -!- FUNCTION: Catalyzes the hydrolysis of diacylglycerol (DAG) to 2-
CC       arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in
CC       tissues. Required for axonal growth during development and for
CC       retrograde synaptic signaling at mature synapses.
CC       {ECO:0000269|PubMed:14610053}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC   -!- ENZYME REGULATION: Inhibited by p-hydroxy-mercuri-benzoate and
CC       HgCl(2), but not to PMSF. Also inhibited by RHC80267, a drug that
CC       blocks 2-AG formation. {ECO:0000269|PubMed:14610053}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=154.7 uM for diacylglycerol {ECO:0000269|PubMed:14610053};
CC         Vmax=33.3 nmol/min/mg enzyme {ECO:0000269|PubMed:14610053};
CC       pH dependence:
CC         Optimum pH is 7.0. {ECO:0000269|PubMed:14610053};
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and pancreas.
CC       {ECO:0000269|PubMed:14610053, ECO:0000269|PubMed:16051747}.
CC   -!- DISEASE: Spinocerebellar ataxia 20 (SCA20) [MIM:608687]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA20 is an autosomal dominant, adult-onset form
CC       characterized by dysarthria due to spasmodic dysphonia followed by
CC       slowly progressive ataxia. {ECO:0000269|PubMed:18801880}. Note=The
CC       disease may be caused by mutations affecting the gene represented
CC       in this entry. A copy number variation consisting of a 260-kb
CC       duplication at chromosome 11q12.2-12.3 is responsible for SCA20.
CC       The critical gene within the duplicated segment may be DAGLA.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31634.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY275377; AAQ17119.1; -; mRNA.
DR   EMBL; AB014559; BAA31634.2; ALT_INIT; mRNA.
DR   EMBL; CH471076; EAW73960.1; -; Genomic_DNA.
DR   EMBL; BC150176; AAI50177.1; -; mRNA.
DR   EMBL; BC150195; AAI50196.1; -; mRNA.
DR   EMBL; BC152453; AAI52454.1; -; mRNA.
DR   CCDS; CCDS31578.1; -.
DR   PIR; T00370; T00370.
DR   RefSeq; NP_006124.1; NM_006133.2.
DR   UniGene; Hs.241564; -.
DR   ProteinModelPortal; Q9Y4D2; -.
DR   BioGrid; 107205; 4.
DR   IntAct; Q9Y4D2; 9.
DR   STRING; 9606.ENSP00000257215; -.
DR   BindingDB; Q9Y4D2; -.
DR   ChEMBL; CHEMBL5545; -.
DR   GuidetoPHARMACOLOGY; 1396; -.
DR   SwissLipids; SLP:000000323; -.
DR   ESTHER; human-DAGLA; Lipase_3.
DR   iPTMnet; Q9Y4D2; -.
DR   PhosphoSitePlus; Q9Y4D2; -.
DR   BioMuta; DAGLA; -.
DR   DMDM; 114149271; -.
DR   MaxQB; Q9Y4D2; -.
DR   PaxDb; Q9Y4D2; -.
DR   PeptideAtlas; Q9Y4D2; -.
DR   PRIDE; Q9Y4D2; -.
DR   Ensembl; ENST00000257215; ENSP00000257215; ENSG00000134780.
DR   GeneID; 747; -.
DR   KEGG; hsa:747; -.
DR   UCSC; uc001nsa.4; human.
DR   CTD; 747; -.
DR   DisGeNET; 747; -.
DR   GeneCards; DAGLA; -.
DR   H-InvDB; HIX0009695; -.
DR   HGNC; HGNC:1165; DAGLA.
DR   HPA; HPA062497; -.
DR   MIM; 608687; phenotype.
DR   MIM; 614015; gene.
DR   neXtProt; NX_Q9Y4D2; -.
DR   OpenTargets; ENSG00000134780; -.
DR   PharmGKB; PA162383158; -.
DR   eggNOG; KOG2088; Eukaryota.
DR   eggNOG; ENOG410XRFI; LUCA.
DR   GeneTree; ENSGT00530000063682; -.
DR   HOGENOM; HOG000015738; -.
DR   HOVERGEN; HBG081435; -.
DR   InParanoid; Q9Y4D2; -.
DR   KO; K13806; -.
DR   OMA; EPRESMQ; -.
DR   OrthoDB; EOG091G04AM; -.
DR   PhylomeDB; Q9Y4D2; -.
DR   TreeFam; TF312928; -.
DR   Reactome; R-HSA-426048; Arachidonate production from DAG.
DR   ChiTaRS; DAGLA; human.
DR   GenomeRNAi; 747; -.
DR   PRO; PR:Q9Y4D2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134780; -.
DR   CleanEx; HS_DAGLA; -.
DR   ExpressionAtlas; Q9Y4D2; baseline and differential.
DR   Genevisible; Q9Y4D2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0043196; C:varicosity; IEA:Ensembl.
DR   GO; GO:0047372; F:acylglycerol lipase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0046340; P:diacylglycerol catabolic process; IDA:UniProtKB.
DR   GO; GO:0071926; P:endocannabinoid signaling pathway; IEA:Ensembl.
DR   GO; GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0042136; P:neurotransmitter biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0098921; P:retrograde trans-synaptic signaling by endocannabinoid; IEA:Ensembl.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002921; Fungal_lipase-like.
DR   Pfam; PF01764; Lipase_3; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Complete proteome; Glycoprotein; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Membrane; Metal-binding;
KW   Neurodegeneration; Phosphoprotein; Polymorphism; Reference proteome;
KW   Spinocerebellar ataxia; Transmembrane; Transmembrane helix.
FT   CHAIN         1   1042       Sn1-specific diacylglycerol lipase alpha.
FT                                /FTId=PRO_0000248347.
FT   TOPO_DOM      1     22       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     23     43       Helical. {ECO:0000255}.
FT   TOPO_DOM     44     60       Extracellular. {ECO:0000255}.
FT   TRANSMEM     61     81       Helical. {ECO:0000255}.
FT   TOPO_DOM     82    101       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    102    122       Helical. {ECO:0000255}.
FT   TOPO_DOM    123    136       Extracellular. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TOPO_DOM    158   1042       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    472    472       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10037}.
FT   ACT_SITE    524    524       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10037}.
FT   MOD_RES     727    727       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5YLM1}.
FT   MOD_RES     729    729       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6WQJ1}.
FT   MOD_RES     732    732       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6WQJ1}.
FT   MOD_RES     743    743       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6WQJ1}.
FT   MOD_RES     782    782       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5YLM1}.
FT   MOD_RES     784    784       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6WQJ1}.
FT   MOD_RES     806    806       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5YLM1}.
FT   MOD_RES     833    833       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5YLM1}.
FT   MOD_RES     847    847       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5YLM1}.
FT   MOD_RES     952    952       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6WQJ1}.
FT   MOD_RES    1023   1023       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q6WQJ1}.
FT   CARBOHYD    133    133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     735    735       G -> V (in dbSNP:rs35056845).
FT                                /FTId=VAR_049822.
FT   VARIANT     889    889       P -> L (in dbSNP:rs3741252).
FT                                /FTId=VAR_027274.
FT   VARIANT     945    945       D -> E (in dbSNP:rs34956386).
FT                                /FTId=VAR_049823.
SQ   SEQUENCE   1042 AA;  114952 MW;  A6E675984E89CB2F CRC64;
     MPGIVVFRRR WSVGSDDLVL PAIFLFLLHT TWFVILSVVL FGLVYNPHEA CSLNLVDHGR
     GYLGILLSCM IAEMAIIWLS MRGGILYTEP RDSMQYVLYV RLAILVIEFI YAIVGIVWLT
     QYYTSCNDLT AKNVTLGMVV CNWVVILSVC ITVLCVFDPT GRTFVKLRAT KRRQRNLRTY
     NLRHRLEEGQ ATSWSRRLKV FLCCTRTKDS QSDAYSEIAY LFAEFFRDLD IVPSDIIAGL
     VLLRQRQRAK RNAVLDEANN DILAFLSGMP VTRNTKYLDL KNSQEMLRYK EVCYYMLFAL
     AAYGWPMYLM RKPACGLCQL ARSCSCCLCP ARPRFAPGVT IEEDNCCGCN AIAIRRHFLD
     ENMTAVDIVY TSCHDAVYET PFYVAVDHDK KKVVISIRGT LSPKDALTDL TGDAERLPVE
     GHHGTWLGHK GMVLSAEYIK KKLEQEMVLS QAFGRDLGRG TKHYGLIVVG HSLGAGTAAI
     LSFLLRPQYP TLKCFAYSPP GGLLSEDAME YSKEFVTAVV LGKDLVPRIG LSQLEGFRRQ
     LLDVLQRSTK PKWRIIVGAT KCIPKSELPE EVEVTTLAST RLWTHPSDLT IALSASTPLY
     PPGRIIHVVH NHPAEQCCCC EQEEPTYFAI WGDNKAFNEV IISPAMLHEH LPYVVMEGLN
     KVLENYNKGK TALLSAAKVM VSPTEVDLTP ELIFQQQPLP TGPPMPTGLA LELPTADHRN
     SSVRSKSQSE MSLEGFSEGR LLSPVVAAAA RQDPVELLLL STQERLAAEL QARRAPLATM
     ESLSDTESLY SFDSRRSSGF RSIRGSPSLH AVLERDEGHL FYIDPAIPEE NPSLSSRTEL
     LAADSLSKHS QDTQPLEAAL GSGGVTPERP PSAAANDEEE EVGGGGGGPA SRGELALHNG
     RLGDSPSPQV LEFAEFIDSL FNLDSKSSSF QDLYCMVVPE SPTSDYAEGP KSPSQQEILL
     RAQFEPNLVP KPPRLFAGSA DPSSGISLSP SFPLSSSGEL MDLTPTGLSS QECLAADKIR
     TSTPTGHGAS PAKQDELVIS AR
//
